A Hong Kong registered clinical diagnostic laboratory has used DiagCor Life Science’s COVID-19 Testing IVD products to participate in the HKSAR Department of Health’s December 2021 SARS-CoV-2 Quality Assurance Program, achieving 100% concordance results. The laboratory used DiagCor Life Science’s DiagPuroTM Nucleic Acid Extraction System, DiagPuroTM Viral DNA/RNA Extraction Reagent and GenoScreenTM SARS-CoV-2 RT-qPCR Assay. The samples included in this SARS-CoV-2 QAP were prepared by Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, HKSAR Government. They are frozen transport medium samples with or without inactivated SARS-CoV-2 (whole virus).
Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.
DiagCor Life Science